NVDA 155.46 ▼0.44%GOOGL 280.20 ▼1.24%MSFT 506.24 ▼2.27%AMD 503.41 ▼0.17%INTC 55.17 ▼0.54%TSMC 359.69 ▼3.68%AMZN 257.89 ▲0.05%META 618.87 ▼1.20%AAPL 351.91 ▼0.25%PLTR 156.56 ▼2.39%
Markets at last close

Models

Moonshot shifts Kimi toward science as coding gains slow

·1 min read

Beijing startup Moonshot AI is redirecting its Kimi language models toward biology, chemistry, and pharmaceutical research as it sees diminishing returns in coding. International director Giacomo Ficari told the Web Summit in Lisbon that scientific work demands smarter AI models than law, finance, or programming.

DP Technology is integrating Kimi K3.1 Pro into its BioMaster research assistant. In a test, the AI analyzed gene data from 3,696 mouse pancreatic cells and identified 100 candidate genes in 90 minutes, compared with an estimated four hours of human work. Such results demonstrate potential research assistance, but fully independent discoveries remain distant. On TCSExam, a 100-problem theoretical computer science benchmark, leading models generated verifiable proofs but failed to solve open conjectures independently.

US competitors face similar limitations. Anthropic’s Claude found an enzyme system in September, while mathematicians criticized OpenAI’s claimed breakthroughs in mathematics and physics. Pharmaceutical researchers also remain cautious: a June Citi survey of 50 US research leaders found 72 percent already using AI broadly, but only 24 percent expected it to noticeably improve drug development success rates.

Originally reported by the-decoder.comRead the source →
Related coverage